Complexins
Introduction of Complexins
Complexin (Cpx), which is expressed mainly in the nervous system, plays a major role in governing SNARE assembly during vesicle fusion. It binds to the SNARE protein complex with a high affinity to regulate both spontaneous and calcium-triggered neurotransmitter release in all synapses. Complexin I to IV (Cpx I to IV) has been identified. Cpx I, II, and III are shown to be expressed in the brain and the retina, whereas Cpx IV is present only at retinal ribbon synapses. Complexins are either facilitators or inhibitors of vesicle exocytosis, functioning to promote evoked neurotransmitter release following an action potential, or acting as fusion clamps to inhibit spontaneous vesicle fusion in the absence of Ca2+.
Structure of Complexins
As a small highly charged cytosolic protein, complexin is hydrophilic with rich glutamic acid and lysine residues. Complexin I consists of four domains: an N terminal domain (NTD, amino acid 1-32), an accessory alpha helix (AH, amino acid 33-47), a central alpha helix (CH, amino acid 48-70), and a carboxy terminal domain (CTD, amino acid 71-134). Amongst, CH domain binds with the SNARE complex that is a prerequisite for all complexin actions. These Cpx domains coordinately potentiate the efficacy of the synchronous exocytotic process.
Fig.1 Structure of complexin-1. (Trimbuch, 2016)
Based on different domains of complexin, comprehensive structure-function analysis has been crucial for understanding the role of complexin in regulating evoked and spontaneous release.
Table.1 Structure-function analysis of complexin domains in different experimental settings. (Trimbuch, 2016)
Function of Complexins
Dependent upon the synaptic activity, complexin carries dual functions with both inhibitory and facilitatory roles in regulating vesicle fusogenicity.
- Acting to Inhibit Fusion
- Acting to Promote Fusion
Inhibition of fusion is necessary to prevent spontaneous exocytosis of vesicles into the synapse. The possible mechanism may involve inhibitory binding of complexin to the assembling SNARE complex. The C-terminal domain of complexin is believed to be responsible for this inhibitory function. In addition, low levels of calcium are thought to induce a comparatively stronger clamping and inhibitory effect of complexin on spontaneous vesicle release.
Independent of the clamping functionality, complexin might exert a fusion-promoting function when a stimulus is transmitted to the synapse. N-terminus of complexin accelerates the kinetics of primed vesicle fusion. This activation pathway is mediated by synaptotagmin-10.
Complexins bind the SNARE complex and regulate the evoked and spontaneous synaptic transmissions. It usually inhibits spontaneous release and promotes evoked transmission to maintain nervous system homeostasis. Creative Biolabs now provides a variety of antibodies, proteins, agonists/antagonists, toxins against various targets in the exocytosis pathway to meet our clients’ requirements. We also provide one-stop customized development services for our clients. If you are interested in our services and products, please do not hesitate to contact us for more detailed information.
Reference
- Trimbuch, T.; Rosenmund, C. Should I stop or should I go? The role of complexin in neurotransmitter release. Nature Reviews Neuroscience. 2016, 17(2): 118.
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)